These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 8575125)
1. Dialysate CA125 in stable CAPD patients: no relation with transport parameters. Pannekeet MM; Koomen GC; Struijk DG; Krediet RT Clin Nephrol; 1995 Oct; 44(4):248-54. PubMed ID: 8575125 [TBL] [Abstract][Full Text] [Related]
2. The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis. Akman S; van Westrhenen R; De Waart DR; Hiralall JK; Zweers MM; Krediet RT Adv Perit Dial; 2003; 19():24-7. PubMed ID: 14763029 [TBL] [Abstract][Full Text] [Related]
3. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability. Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115 [TBL] [Abstract][Full Text] [Related]
4. Dialysate cancer antigen 125 levels in children treated with peritoneal dialysis. Bouts AH; Groothoff JW; van Amstel SP; Zweers MM; Davin JC; Krediet RT Adv Perit Dial; 2000; 16():328-31. PubMed ID: 11045322 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients. Passadakis P; Panagoutsos S; Thodis E; Tsivara I; Sopassi F; Kartali S; Vargemezis V Adv Perit Dial; 1999; 15():40-4. PubMed ID: 10682070 [TBL] [Abstract][Full Text] [Related]
6. Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Visser CE; Brouwer-Steenbergen JJ; Betjes MG; Koomen GC; Beelen RH; Krediet RT Nephrol Dial Transplant; 1995; 10(1):64-9. PubMed ID: 7724031 [TBL] [Abstract][Full Text] [Related]
7. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters. Lai KN; Lai KB; Szeto CC; Ho KK; Poon P; Lam CW; Leung JC Am J Kidney Dis; 1997 May; 29(5):699-705. PubMed ID: 9159303 [TBL] [Abstract][Full Text] [Related]
8. Influence of dialysis duration, peritoneal transport parameters, and gender on effluent CA125 concentration in patients on peritoneal dialysis. Mojahedi MJ; Hami M; Shakeri MT; Hekmat R Iran J Kidney Dis; 2007 Oct; 1(2):78-81. PubMed ID: 19363281 [TBL] [Abstract][Full Text] [Related]
10. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide? Douma CE; de Waart DR; Struijk DG; Krediet RT Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport. Rodrigues A; Martins M; Santos MJ; Fonseca I; Oliveira JC; Cabrita A; Melo e Castro J; Krediet RT Adv Perit Dial; 2004; 20():8-12. PubMed ID: 15384786 [TBL] [Abstract][Full Text] [Related]
12. The relationship between peritoneal transport characteristics and messenger RNA expression of aquaporin in the peritoneal dialysis effluent of CAPD patients. Szeto CC; Lai KB; Chow KM; Szeto CY; Li PK J Nephrol; 2005; 18(2):197-203. PubMed ID: 15931648 [TBL] [Abstract][Full Text] [Related]
13. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD. Serlie MJ; Struijk DG; de Blok K; Krediet RT Adv Perit Dial; 1997; 13():29-32. PubMed ID: 9360646 [TBL] [Abstract][Full Text] [Related]
14. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis. Smit W; de Waart DR; Struijk DG; Krediet RT Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247 [TBL] [Abstract][Full Text] [Related]
15. Influence of pH-neutral peritoneal dialysis solution. Moriishi M; Kawanishi H; Kawai T; Takahashi S; Hirai T; Shishida M; Watanabe H; Takahashi N Adv Perit Dial; 2002; 18():68-71. PubMed ID: 12402590 [TBL] [Abstract][Full Text] [Related]
16. Peritoneal kinetics of cancer antigen 125 in peritoneal dialysis patients: the relationship with peritoneal outcome. Jiménez C; Díaz C; Selgas R; Auxiliadora Bajo M; del Peso G; Sánchez-Tomero JA; Gonzalez-Gancedo P Adv Perit Dial; 1999; 15():36-9. PubMed ID: 10682069 [TBL] [Abstract][Full Text] [Related]
17. Necessity of correcting cancer antigen 125 appearance rates by body surface area. Kawanishi H; Moriishi M; Harada Y; Sakikubo E; Nagai T; Tsuchiya S Adv Perit Dial; 2000; 16():22-5. PubMed ID: 11045255 [TBL] [Abstract][Full Text] [Related]
18. Dialysate CA125 levels in children on continuous peritoneal dialysis. Turhan P; Sever L; Caliskan S; Kasapcopur O; Sever A; Hacibekiroglu M; Arisoy N Pediatr Nephrol; 2005 Nov; 20(11):1615-21. PubMed ID: 16133054 [TBL] [Abstract][Full Text] [Related]